Patient Capital Management, LLC 13F holdings and portfolio analysis

已就緒Patient Capital Management, LLC · Samantha McLemore

登錄後可基於當前選中的策略克隆一個新分支，繼續在新分支裏調整參數與權重。

官方策略
用户分支
返回基金列表

Baseline

分析消息
分支：
Baselinetested
策略問答參考3 條參考問答

基於這隻基金最新一期數據預生成的問答，可直接作為對話上下文使用。

baseline13FChat AI
What does directly following the disclosed baseline portfolio expose an investor to?

Directly following the baseline exposes an investor to a concentrated, filing-lagged portfolio with meaningful idiosyncratic and sector-rotation risk. The top 5 holdings are 28.92%, the top 10 are 51.49%, and the top 20 are 81.99%. Health Care is 25.28% and Consumer Discretionary is 22.63%, so nearly half the portfolio sits in those two sectors alone. The strategy also depends on delayed 13F implementation, with 408 trades and turnover reaching 66.78% in one rebalance period, so investors are not buying the manager’s positions in real time.

↳Show the baseline’s top holdings and sector weights alongside its turnover history.
baseline13FChat AI
Which recent baseline periods best explain the risk-return trade-off?

The trade-off is easiest to see in the contrast between a few strong winning periods and several sharp setbacks. The best recent period was 2024-06-30, when the baseline returned 19.33% versus SPY’s 9.83%, a 9.5-point excess return, and 2023-03-31 also beat by 4.74 points. But the downside was real: 2022-12-31 lost 8.62% while SPY lost only 0.25%, and 2024-03-31 fell 2.4% while SPY gained 2.31%, a -4.71-point excess result. Those swings help explain why the full-period return is respectable at 11.22% annualized, yet the max drawdown still reached -23.04% and the benchmark-relative record is described as inconsistent.

↳Rank the baseline periods by excess return and separate upside capture from downside damage.
baseline13FChat AI
What should a user inspect next before deciding whether the baseline is acceptable?

A user should inspect three things next: concentration, sector dependence, and implementation drag. First, top 10 concentration is already 51.49%, so a few names dominate results. Second, Health Care is 25.28% and Consumer Discretionary is 22.63%, which means sector outcomes matter a lot. Third, the backtest warns that delayed disclosure matters: there were 408 trades, total estimated cost was 0.5017, and one period saw 66.78% turnover. Those details determine whether the baseline is tolerable as a copy strategy rather than just an interesting holdings snapshot.

↳Help me decide whether the baseline concentration and turnover are too high for a copycat investor.
登錄後即可基於上方策略與右側數據，直接與 AI 對話分析。
登錄後開始對話…
可參考左欄策略與右欄數據。